GNXAX
Price
$14.46
Change
-$0.01 (-0.07%)
Updated
Sep 11 closing price
Net Assets
21.36M
RLLGX
Price
$85.88
Change
+$0.27 (+0.32%)
Updated
Sep 11 closing price
Net Assets
91.39B
Interact to see
Advertisement

GNXAX vs RLLGX

GNXAX vs RLLGX Comparison Chart in %
View a ticker or compare two or three
VS
GNXAX vs. RLLGX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNXAX is a Hold and RLLGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLLGX has more cash in the bank: 91.4B vs. GNXAX (21.4M). RLLGX pays higher dividends than GNXAX: RLLGX (0.88) vs GNXAX (0.00). GNXAX was incepted earlier than RLLGX: GNXAX (9 years) vs RLLGX (17 years). GNXAX (2.59) is less costly to investors than RLLGX (0.65). GNXAX is a more actively managed with annual turnover of: 114.00 vs. RLLGX (41.00). RLLGX has a lower initial minimum investment than GNXAX: RLLGX (250) vs GNXAX (2500). RLLGX annual gain was more profitable for investors over the last year : 9.55 vs. GNXAX (-17.08). RLLGX return over 5 years is better than : -7.42 vs. GNXAX (-20.32).
GNXAXRLLGXGNXAX / RLLGX
Total Expense Ratio1.650.65254%
Annual Report Gross Expense Ratio2.590.65398%
Fund Existence9 years17 years-
Gain YTD-17.78412.570-141%
Front Load6%N/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets21.4M91.4B0%
Annual Yield % from dividends0.000.88-
Returns for 1 year-17.089.55-179%
Returns for 3 years35.7439.2491%
Returns for 5 years-20.32-7.42274%
Returns for 10 yearsN/A90.54-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCVRX28.60N/A
N/A
Goldman Sachs Large Cp Val Insghts R
MABAX20.14N/A
N/A
BlackRock Large Cap Focus Value Instl
LGLUX58.91N/A
N/A
Lord Abbett Growth Leaders R5
MXMTX11.48N/A
N/A
Empower Small Cap Growth Investor
AIHHX6.70N/A
N/A
Aristotle Small/Mid Cap Equity I-2